ALKS
Price
$28.82
Change
-$0.08 (-0.28%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
4.55B
27 days until earnings call
PRGO
Price
$26.57
Change
-$0.04 (-0.15%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
4.35B
41 days until earnings call
Interact to see
Advertisement

ALKS vs PRGO

Header iconALKS vs PRGO Comparison
Open Charts ALKS vs PRGOBanner chart's image
Alkermes
Price$28.82
Change-$0.08 (-0.28%)
Volume$29.26K
Capitalization4.55B
Perrigo
Price$26.57
Change-$0.04 (-0.15%)
Volume$5.85K
Capitalization4.35B
ALKS vs PRGO Comparison Chart in %
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. PRGO commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Buy and PRGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ALKS: $28.90 vs. PRGO: $26.62)
Brand notoriety: ALKS and PRGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 73% vs. PRGO: 61%
Market capitalization -- ALKS: $4.55B vs. PRGO: $4.35B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. PRGO’s [@Pharmaceuticals: Other] market capitalization is $4.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 2 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • ALKS’s FA Score: 2 green, 3 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ALKS is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 3 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 3 bullish, 6 bearish.
  • PRGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а -1.47% price change this week, while PRGO (@Pharmaceuticals: Other) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.82%. For the same industry, the average monthly price growth was +13.89%, and the average quarterly price growth was +90.97%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 23, 2025.

PRGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.82% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) and PRGO($4.35B) have the same market capitalization . PRGO has higher P/E ratio than ALKS: PRGO (341.25) vs ALKS (8.90). PRGO YTD gains are higher at: 5.727 vs. ALKS (0.487). PRGO (525M) and ALKS (519M) have comparable annual earnings (EBITDA) . ALKS (773M) and PRGO (751M) have equal amount of cash in the bank . ALKS has less debt than PRGO: ALKS (372M) vs PRGO (4.07B). PRGO has higher revenues than ALKS: PRGO (4.66B) vs ALKS (1.66B).
ALKSPRGOALKS / PRGO
Capitalization4.55B4.35B105%
EBITDA519M525M99%
Gain YTD0.4875.7278%
P/E Ratio8.90341.253%
Revenue1.66B4.66B36%
Total Cash773M751M103%
Total Debt372M4.07B9%
FUNDAMENTALS RATINGS
ALKS vs PRGO: Fundamental Ratings
ALKS
PRGO
OUTLOOK RATING
1..100
6456
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
3891
PRICE GROWTH RATING
1..100
5853
P/E GROWTH RATING
1..100
102
SEASONALITY SCORE
1..100
503

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (66) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALKS (99) in the Biotechnology industry. This means that PRGO’s stock grew somewhat faster than ALKS’s over the last 12 months.

ALKS's Profit vs Risk Rating (30) in the Biotechnology industry is significantly better than the same rating for PRGO (100) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew significantly faster than PRGO’s over the last 12 months.

ALKS's SMR Rating (38) in the Biotechnology industry is somewhat better than the same rating for PRGO (91) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's Price Growth Rating (53) in the Pharmaceuticals Other industry is in the same range as ALKS (58) in the Biotechnology industry. This means that PRGO’s stock grew similarly to ALKS’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as ALKS (10) in the Biotechnology industry. This means that PRGO’s stock grew similarly to ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSPRGO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 7 days ago
61%
Declines
ODDS (%)
Bearish Trend 7 days ago
63%
Bearish Trend 14 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NUEM33.191.00
+3.11%
Nuveen ESG Emerging Markets Equity ETF
AAPX18.320.21
+1.16%
T-Rex 2X Long Apple Daily Target ETF
POCT40.920.01
+0.02%
Innovator U.S. Equity Power Buf ETF™ Oct
IHI61.77-0.12
-0.19%
iShares US Medical Devices ETF
FTXN27.33-0.23
-0.83%
First Trust Nasdaq Oil & Gas ETF

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with ESPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then ESPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-1.53%
ESPR - ALKS
35%
Loosely correlated
-5.61%
VTRS - ALKS
34%
Loosely correlated
-0.67%
PAHC - ALKS
34%
Loosely correlated
-0.08%
COLL - ALKS
34%
Loosely correlated
-1.06%
PRGO - ALKS
33%
Poorly correlated
-0.49%
More